Economic feasibility analysis of using serum C-reactive protein as a screening tool for high-risk people with diabetes complications in the community: an empirical analysis using CHARLS data

Abstract

Abstract Objectives: To explore the economic feasibility of using serum C-reactive protein as a screening tool for groups at high risk of diabetes-related complications in Chinese communities. Methods: In this study, we use data from China Health and Retirement Longitudinal Survey (CHARLS) in 2015. Thenthe Markov model was used to explore the economic feasibility of using serum C-reactive protein as a screening tool for high-risk groups of diabetic complications in Chinese communities. Results: In our study，27.8% of patients with serum C-reactive protein were at high risk. According to the Markov, it predict that using serum C-reactive as a screening tool for high risk groups of diabetes will reduce the economic burden by ¥50,350.01 per individual compared with the control group . According to the current population proportion of diabetes in China, it estimate that will reduce the economic burden by ¥5840.6 billion（$837.58 billion）,the mortality rate by 8.3% , and the incidence rate of myocardial infarction by 42.2% in five years .This is equivalent to saving 9.628 million lives of diabetes patients and reducing myocardial infarction events by 48.72 million and the economic burden by ¥3134.84 billion ($449.6 billion). Conclusions: In this study, It is economically feasible to use serum C-reactive protein as a screening tool for high risk groups of diabetes complications in the China community.